This inventor holds 34 USPTO granted patents and 26 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Kinase Inhibitors. Top assignees: Denali Therapeutics Inc., Genentech, Inc.. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Millbrae, CA (US) (2017 - 2021)
- South San Francisco, CA (US) (2014 - 2023)
- San Mateo, CA (US) (2017 - 2024)
Company Filing History:
Years Active: 2014-2026
Areas of Expertise:
Sure, I can help you with that! Let's start with the article about inventor Jianwen A Feng:
Title: Inventor Spotlight: Jianwen A Feng
Introduction:
Jianwen A Feng is an innovative inventor based in San Mateo, CA, with a remarkable track record in the field of eukaryotic initiation factor 2B modulators. With 27 patents to his name, Jianwen A Feng has made significant contributions to the pharmaceutical industry.
Latest Patents:
Jianwen A Feng's latest patents include groundbreaking inventions such as "Compounds, compositions and methods" and "Modulators of eukaryotic initiation factor 2B, compositions and methods." These patents focus on developing modulators of eukaryotic initiation factor 2B and their various applications in pharmacology.
Career Highlights:
Having worked for esteemed companies like Denali Therapeutics Inc. and Genentech, Inc., Jianwen A Feng has honed his skills and expertise in drug development and innovation. His dedication to pushing the boundaries of pharmaceutical research is evident in his patent portfolio and achievements.
Collaborations:
Throughout his career, Jianwen A Feng has collaborated with talented professionals in the industry, including coworkers like Anthony A Estrada and Zachary Kevin Sweeney. These collaborations have fostered creativity and led to the successful implementation of novel ideas in the field of pharmaceuticals.
Conclusion:
In conclusion, Jianwen A Feng stands out as a prominent inventor with a keen focus on eukaryotic initiation factor 2B modulators and their implications in drug discovery. His work continues to shape the future of pharmacology, and his innovative spirit serves as an inspiration to aspiring inventors in the industry.
I hope this article provides you with valuable insights into the accomplishments of Jianwen A Feng! If you need more information or assistance, feel free to ask.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile